Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Sees Significant Drop in Short Interest

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Rating) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 105,100 shares, a decline of 15.9% from the May 15th total of 125,000 shares. Based on an average trading volume of 110,700 shares, the short-interest ratio is currently 0.9 days.

Daiichi Sankyo stock opened at $23.06 on Friday. The company has a 50 day moving average price of $24.87 and a 200-day moving average price of $23.56. Daiichi Sankyo has a fifty-two week low of $18.05 and a fifty-two week high of $29.09.

About Daiichi Sankyo (Get Rating)

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.